CLDN18 and non-small cell lung carcinoma: In conclusion, this study provided clues of the values of AT II-associated genes (AQP4, SFTPB, SFTPC, SFTPD, CLDN18, FOXA2, NKX2-1, and PGC) as clinical biomarkers and therapeutic targets in NSCLC.